These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


523 related items for PubMed ID: 25682948

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. IL-12Rβ2 is essential for the development of experimental cerebral malaria.
    Fauconnier M, Palomo J, Bourigault ML, Meme S, Szeremeta F, Beloeil JC, Danneels A, Charron S, Rihet P, Ryffel B, Quesniaux VF.
    J Immunol; 2012 Feb 15; 188(4):1905-14. PubMed ID: 22238458
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. IL-33 receptor ST2 regulates the cognitive impairments associated with experimental cerebral malaria.
    Reverchon F, Mortaud S, Sivoyon M, Maillet I, Laugeray A, Palomo J, Montécot C, Herzine A, Meme S, Meme W, Erard F, Ryffel B, Menuet A, Quesniaux VFJ.
    PLoS Pathog; 2017 Apr 15; 13(4):e1006322. PubMed ID: 28448579
    [Abstract] [Full Text] [Related]

  • 6. IFN-γ-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain.
    Villegas-Mendez A, Greig R, Shaw TN, de Souza JB, Gwyer Findlay E, Stumhofer JS, Hafalla JC, Blount DG, Hunter CA, Riley EM, Couper KN.
    J Immunol; 2012 Jul 15; 189(2):968-79. PubMed ID: 22723523
    [Abstract] [Full Text] [Related]

  • 7. IRGM3 contributes to immunopathology and is required for differentiation of antigen-specific effector CD8+ T cells in experimental cerebral malaria.
    Guo J, McQuillan JA, Yau B, Tullo GS, Long CA, Bertolino P, Roediger B, Weninger W, Taylor GA, Hunt NH, Ball HJ, Mitchell AJ.
    Infect Immun; 2015 Apr 15; 83(4):1406-17. PubMed ID: 25644000
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Induction of pro-inflammatory mediators in Plasmodium berghei infected BALB/c mice breaks blood-brain-barrier and leads to cerebral malaria in an IL-12 dependent manner.
    Schmidt KE, Schumak B, Specht S, Dubben B, Limmer A, Hoerauf A.
    Microbes Infect; 2011 Sep 15; 13(10):828-36. PubMed ID: 21609776
    [Abstract] [Full Text] [Related]

  • 16. Infection-Induced Resistance to Experimental Cerebral Malaria Is Dependent Upon Secreted Antibody-Mediated Inhibition of Pathogenic CD8+ T Cell Responses.
    Shaw TN, Inkson CA, Villegas-Mendez A, Pattinson DJ, Strangward P, Else KJ, Draper SJ, Zeef LAH, Couper KN.
    Front Immunol; 2019 Sep 15; 10():248. PubMed ID: 30846985
    [Abstract] [Full Text] [Related]

  • 17. Prevention of experimental cerebral malaria by Flt3 ligand during infection with Plasmodium berghei ANKA.
    Tamura T, Kimura K, Yuda M, Yui K.
    Infect Immun; 2011 Oct 15; 79(10):3947-56. PubMed ID: 21807908
    [Abstract] [Full Text] [Related]

  • 18. Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria.
    Amante FH, Haque A, Stanley AC, Rivera Fde L, Randall LM, Wilson YA, Yeo G, Pieper C, Crabb BS, de Koning-Ward TF, Lundie RJ, Good MF, Pinzon-Charry A, Pearson MS, Duke MG, McManus DP, Loukas A, Hill GR, Engwerda CR.
    J Immunol; 2010 Sep 15; 185(6):3632-42. PubMed ID: 20720206
    [Abstract] [Full Text] [Related]

  • 19. Host Resistance to Plasmodium-Induced Acute Immune Pathology Is Regulated by Interleukin-10 Receptor Signaling.
    Claser C, De Souza JB, Thorburn SG, Grau GE, Riley EM, Rénia L, Hafalla JCR.
    Infect Immun; 2017 Jun 15; 85(6):. PubMed ID: 28396319
    [Abstract] [Full Text] [Related]

  • 20. Phenylhydrazine administration accelerates the development of experimental cerebral malaria.
    Zhu X, Liu J, Feng Y, Pang W, Qi Z, Jiang Y, Shang H, Cao Y.
    Exp Parasitol; 2015 Sep 15; 156():1-11. PubMed ID: 26005191
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.